FDA approves AcrySof IQ Aspheric IOL for patients undergoing cataract surgery- Alcon/Novartis
Alcon, a division of Novartis, has received FDA approval for its AcrySof IQ Aspheric IOL (intraocular lens) with the UltraSert Pre-loaded Delivery System for patients undergoing cataract surgery. The UltraSert Pre-loaded Delivery System received the European CE mark in June 2015.
This new delivery system combines the control of a manually loaded device with the safety and convenience of a disposable, pre-loaded injector to optimize the implantation of the AcrySof IQ Aspheric IOL into the cataract patient's eye. Driving at night is a common cause of anxiety among cataract patients. Adding obstacles such as fog, glare, and high speeds represents an even greater risk.
Under similar conditions when measured against a control lens, the AcrySof IQ Aspheric IOL:
- Performed functionally better in 34 of 36 conditions.
- Improved functional vision under real-world challenges.
- Allowed patients more time to take appropriate action.
Comment: Popular aspheric IOLs that are FDA-approved and available in the US include: Tecnis Aspheric (Abbott Medical Optics), AcrySof IQ (Alcon), SofPort AO (Bausch + Lomb), and Softec HD (Lenstec).
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.